Control Bionics CEO Jeremy Steele talked with Proactive about the company's integration of Apple’s Brain-Computer Interface (BCI) Human Interface Device (HID) protocol into its assistive technology products.
Steele explained that Control Bionics, listed on the ASX since 2020, has been leveraging surface electromyography (EMG) technology for two decades. This technology detects and analyses electrical activity in muscles, enabling individuals with limited mobility to interact with digital systems through intentional and involuntary muscle signals.
The integration with Apple’s BCI HID protocol allows users to control Apple products using their physiological signals. Steele said, “It gives individuals an ability to understand the strength of the signal from their muscle and how that's represented inside an Apple product.” He highlighted how the partnership enhances accessibility, enabling users to engage with apps or games more intuitively.
Steele noted that Control Bionics is one of only three companies globally with access to the protocol. The company is now in discussions with distributors of Apple-based devices, opening new international growth avenues.
Use cases range from intuitive speech support for those with impaired voice, to third-party development of new applications based on physiological control. “It’s a wonderful way in which your body can really drive and control technology,” Steele said.
For more videos like this, visit Proactive’s YouTube channel. Don’t forget to like the video, subscribe to the channel, and enable notifications for future content.
#ControlBionics #AppleIntegration #Apple #AssistiveTech #AccessibleTechnology#MedicalDevices